Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does cost-effectiveness play a role in clinical trials?

Tace Steele1, Manjiri Pawaskar, Rajesh Balkrishnan

  • 1Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 2715-1071, USA.

Dermatologic Therapy
|June 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling the clinical and economic impact of universal varicella vaccination in Belgium with dynamic population.

PLOS global public health·2026
Same author

Dermatologist prescriptions for biologics contribute to thousands of tons of plastic waste.

Dermatology online journal·2025
Same author

Diabetes Belt has lower efficiency in providing diabetes preventive care than surrounding counties.

Health services & outcomes research methodology·2025
Same author

Development and validation of the telemedicine facilitators scale: A novel measure of telemedicine facilitators and use.

Journal of telemedicine and telecare·2025
Same author

Modeling the effects of improving varicella vaccination coverage on clinical and economic outcomes in Peru.

Human vaccines & immunotherapeutics·2025
Same author

Impact of Universal Varicella Vaccination in Israel: A Time-series Analysis, 2003 to 2020.

The Pediatric infectious disease journal·2025

Pharmacoeconomic studies assess treatment costs, including direct, indirect, and intangible expenses. Understanding these costs is crucial for healthcare decisions and resource allocation in dermatology.

Area of Science:

  • Pharmacoeconomics
  • Health Economics
  • Dermatology

Background:

  • Cost assessment is vital for evaluating healthcare interventions alongside efficacy and safety.
  • Understanding treatment costs involves direct, indirect, and intangible components.
  • Different stakeholders (insurers, patients, society) perceive costs differently.

Purpose of the Study:

  • To review cost analyses in pharmacoeconomic studies.
  • To examine the application of cost analyses in dermatological treatments.
  • To highlight the influence of cost studies on healthcare decision-making.

Main Methods:

  • Review of pharmacoeconomic cost analyses.
  • Application of cost analysis principles to specific dermatological conditions.

Related Experiment Videos

  • Examination of cost data collection within clinical trials.

    • Main Results:

    • Cost analyses categorize expenses into direct, indirect, and intangible costs.
    • Cost studies inform decisions on implementing therapies for psoriasis, atopic dermatitis, and basal cell carcinoma.
    • Incorporating cost data into clinical trials is essential for informed decision-making.

    Conclusions:

    • Pharmacoeconomic evaluations are integral to treatment assessment.
    • Cost data influences clinicians, policymakers, and payers.
    • Integrating cost assessment into clinical trials facilitates evidence-based healthcare decisions.